Kelley Shannon T. - 05 Aug 2024 Form 3 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
General Counsel
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Issuer symbol
MDGL
Transactions as of
05 Aug 2024
Net transactions value
$0
Form type
3
Filing time
15 Aug 2024, 19:52:55 UTC
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDGL Common Stock 2,767 05 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDGL Stock Option (Right to Buy) 05 Aug 2024 Common Stock 4,169 $243.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, which vest as to 25% of the shares on each of January 16, 2025, January 16, 2026, January 16, 2027 and January 16, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
F2 The option vests as to 25% of the shares on the first anniversary of the date of grant (January 16, 2025) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Remarks:

Exhibit 24: Power of Attorney